These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3776113)

  • 21. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antithrombin III inhibition of the reaction to thrombin excitation of the anticoagulation system].
    Strukova SM; Umarova BA; Golubeva MG; Dugina TN; Bashkov GV
    Biull Eksp Biol Med; 1987 Mar; 103(3):268-70. PubMed ID: 3828498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombin III assay using thrombin in disseminated intravascular coagulation (DIC), other thromboembolic disorders and hepatic diseases.
    Saxena V; Mishra DK; Subramanya H; Satyanarayana S; Sharma A
    Indian J Pathol Microbiol; 2004 Apr; 47(2):210-2. PubMed ID: 16295470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombin III. Key factor in extracorporeal circulation.
    Ranucci M
    Minerva Anestesiol; 2002 May; 68(5):454-7. PubMed ID: 12029263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Replacement therapy of acquired antithrombin III deficiency in experimental nephrotic syndrome].
    Bashkov GV; Kalishevskaia TM
    Biull Eksp Biol Med; 1987 Sep; 104(9):278-81. PubMed ID: 3663906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ; Ofosu FA; Buchanan MR
    Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anticoagulant and nonenzymatic fibrinolytic activity of plasma in animals after intravenous injection of a heparin-antithrombin III complex].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biull Eksp Biol Med; 1985 Jan; 99(1):62-4. PubMed ID: 3967074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preoperative detection of the postoperative risk of thromboembolism. Results of a prospective study. III. Hemostaseologic findings].
    Vogel G; Hindersin P; Huyke R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):502-4. PubMed ID: 6083919
    [No Abstract]   [Full Text] [Related]  

  • 29. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
    Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
    Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diphasic increase in thrombin-antithrombin III complex in blood from the internal jugular vein following severe head injury.
    Suzuki M; Motohashi O; Nishino A; Shiina V; Mizoi K; Yoshimoto T; Kameyama M; Onuma T
    Thromb Haemost; 1994 Jan; 71(1):155-7. PubMed ID: 8165638
    [No Abstract]   [Full Text] [Related]  

  • 31. Thrombin formation in vitro in response to shear-induced activation of platelets.
    Fallon AM; Marzec UM; Hanson SR; Yoganathan AP
    Thromb Res; 2007; 121(3):397-406. PubMed ID: 17532367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of perioperative thromboembolism and antithrombin III levels in patients who are to undergo major gynecologic operations].
    Viceić M; Janković D; Bernat T; Vecek N; Ljubojević N
    Lijec Vjesn; 1988 Nov; 110(11):359-60. PubMed ID: 3231001
    [No Abstract]   [Full Text] [Related]  

  • 33. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring complex formation in the blood-coagulation cascade using aptamer-coated SAW sensors.
    Gronewold TM; Glass S; Quandt E; Famulok M
    Biosens Bioelectron; 2005 Apr; 20(10):2044-52. PubMed ID: 15741074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
    Halbmayer WM; Haushofer A; Toth E
    Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of thrombin formation during hemodialysis with triglyceride.
    Kitamoto Y; Fukui H; Matsushita K; Sato T; Soejima H; Noguchi Y; Kasama T
    ASAIO J; 1993; 39(3):M581-3. PubMed ID: 8268604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heparin and antiheparin in young children. 1. Report: development of a method for determining heparin and antiheparin in the antithrombin-thrombin system].
    Domula M; Weissbach G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):808-23. PubMed ID: 6188669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative evaluation of 3 methods of study of antithrombin III].
    Nakabanda A; Katsadze IuL; Kotovshchikova MA
    Lab Delo; 1984; (5):276-9. PubMed ID: 6204109
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of thromboembolism with low molecular weight heparin (Fragmin) in obstetrics].
    Krauss T; Rath W; Dittmer U; Kuhn W
    Z Geburtshilfe Perinatol; 1994 Aug; 198(4):120-5. PubMed ID: 7975797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.